• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶对毛细血管形态发生的调控

Matrix metalloproteinase control of capillary morphogenesis.

作者信息

Ghajar Cyrus M, George Steven C, Putnam Andrew J

机构信息

Department of Biomedical Engineering, University of California, Irvine, Irvine, CA 92697, USA.

出版信息

Crit Rev Eukaryot Gene Expr. 2008;18(3):251-78. doi: 10.1615/critreveukargeneexpr.v18.i3.30.

DOI:10.1615/critreveukargeneexpr.v18.i3.30
PMID:18540825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2905732/
Abstract

Matrix metalloproteinases (MMPs) play crucial roles in a variety of normal (e.g., blood vessel formation, bone development) and pathophysiological (e.g., wound healing, cancer) processes. This is not only due to their ability to degrade the surrounding extracellular matrix (ECM), but also because MMPs function to reveal cryptic matrix binding sites, release matrix-bound growth factors inherent to these processes, and activate a variety of cell surface molecules. The process of blood vessel formation, in particular, is regulated by what is widely classified as the angiogenic switch: a mixture of both pro- and antiangiogenic factors that function to counteract each other unless the stimuli from one side exceeds the other to disrupt the quiescent state. Although it was initially thought that MMPs were strictly proangiogenic, new functions for this proteolytic family, such as mediating vascular regression and generating matrix fragments with antiangiogenic capacities, have been discovered in the last decade. These findings cast MMPs as multifaceted pro- and antiangiogenic effectors. The purpose of this review is to introduce the reader to the general structure and characterization of the MMP family and to discuss the temporal and spatial regulation of their gene expression and enzymatic activity in the following crucial steps associated with angiogenesis: degradation of the vascular basement membrane, proliferation and invasion of endothelial cells within the subjacent ECM, organization into immature tubules, maturation of these nascent vessels, and the pruning and regression of the vascular network.

摘要

基质金属蛋白酶(MMPs)在多种正常(如血管形成、骨骼发育)和病理生理(如伤口愈合、癌症)过程中发挥着关键作用。这不仅是因为它们具有降解周围细胞外基质(ECM)的能力,还因为MMPs能够揭示隐藏的基质结合位点,释放这些过程中固有的基质结合生长因子,并激活多种细胞表面分子。特别是血管形成过程,受到广泛分类为血管生成开关的调节:这是一种促血管生成因子和抗血管生成因子的混合物,它们相互作用以抵消彼此的作用,除非来自一侧的刺激超过另一侧以破坏静止状态。尽管最初认为MMPs严格促进血管生成,但在过去十年中发现了这个蛋白水解家族的新功能,如介导血管消退和产生具有抗血管生成能力的基质片段。这些发现表明MMPs是多方面的促血管生成和抗血管生成效应器。本综述的目的是向读者介绍MMP家族的一般结构和特征,并讨论它们在与血管生成相关的以下关键步骤中的基因表达和酶活性的时空调节:血管基底膜的降解、内皮细胞在相邻ECM内的增殖和侵袭、组织成未成熟的小管、这些新生血管的成熟以及血管网络的修剪和消退。

相似文献

1
Matrix metalloproteinase control of capillary morphogenesis.基质金属蛋白酶对毛细血管形态发生的调控
Crit Rev Eukaryot Gene Expr. 2008;18(3):251-78. doi: 10.1615/critreveukargeneexpr.v18.i3.30.
2
Matrix metalloproteinases and angiogenesis.基质金属蛋白酶与血管生成
J Cell Mol Med. 2005 Apr-Jun;9(2):267-85. doi: 10.1111/j.1582-4934.2005.tb00355.x.
3
Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.基质金属蛋白酶-19 通过从纤溶酶原生成类似血管抑素的片段来抑制内皮细胞的生长。
BMC Biochem. 2011 Jul 25;12:38. doi: 10.1186/1471-2091-12-38.
4
Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease.基质金属蛋白酶:将MT1-MMP用作血管生成相关疾病治疗靶点的新途径。
Curr Pharm Des. 2007;13(17):1787-802. doi: 10.2174/138161207780831284.
5
Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model.基质金属蛋白酶-3组织抑制剂的强制表达影响功能性毛细血管形态发生并抑制小鼠肿瘤模型中的肿瘤生长。
Blood. 2002 Nov 1;100(9):3361-8. doi: 10.1182/blood.V100.9.3361.
6
Metalloproteinases and their inhibitors in angiogenesis.血管生成中的金属蛋白酶及其抑制剂
Expert Rev Mol Med. 2003 Sep 22;5(23):1-39. doi: 10.1017/S1462399403006628.
7
Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.下一代基质金属蛋白酶抑制剂——新策略带来新前景。
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1927-1939. doi: 10.1016/j.bbamcr.2017.06.009. Epub 2017 Jun 19.
8
Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization.内皮细胞外基质:血管形态发生和新生血管稳定过程中的生物合成、重塑及功能
Circ Res. 2005 Nov 25;97(11):1093-107. doi: 10.1161/01.RES.0000191547.64391.e3.
9
Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms.间质细胞通过不同的蛋白水解机制刺激毛细血管形态发生。
Exp Cell Res. 2010 Mar 10;316(5):813-25. doi: 10.1016/j.yexcr.2010.01.013. Epub 2010 Jan 11.
10
Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.炎症介导的人类疾病中基质金属蛋白酶抑制剂的生理特性、功能及研究趋势
Curr Med Chem. 2023;30(18):2075-2112. doi: 10.2174/0929867329666220823112731.

引用本文的文献

1
Role and Mechanisms of Angiogenesis in Tumours.肿瘤血管生成的作用及机制
Biology (Basel). 2025 Jun 25;14(7):756. doi: 10.3390/biology14070756.
2
Evaluating Matrix Metalloproteinase Activity in Human Hepatocellular Carcinoma Tissues and Cells with Gelatin Zymography.用明胶酶谱法评估人肝癌组织和细胞中的基质金属蛋白酶活性
Methods Mol Biol. 2025;2918:255-268. doi: 10.1007/978-1-0716-4482-9_22.
3
New Perspectives on the Role of Nuclear Proteases in Cell Death Pathways.核蛋白酶在细胞死亡途径中作用的新视角
Biology (Basel). 2023 May 31;12(6):797. doi: 10.3390/biology12060797.
4
Favorable Biological Performance Regarding the Interaction between Gold Nanoparticles and Mesenchymal Stem Cells.金纳米颗粒与间充质干细胞相互作用的良好生物学性能。
Int J Mol Sci. 2022 Dec 20;24(1):5. doi: 10.3390/ijms24010005.
5
Insights Into the Role of Matrix Metalloproteinases in Cancer and its Various Therapeutic Aspects: A Review.基质金属蛋白酶在癌症及其各种治疗方面的作用洞察:综述
Front Mol Biosci. 2022 Sep 29;9:896099. doi: 10.3389/fmolb.2022.896099. eCollection 2022.
6
Microfluidic Electroceuticals Platform for Therapeutic Strategies of Intervertebral Disc Degeneration: Effects of Electrical Stimulation on Human Nucleus Pulposus Cells under Inflammatory Conditions.用于治疗椎间盘退变的微流控电疗平台:在炎症条件下电刺激对人髓核细胞的影响。
Int J Mol Sci. 2022 Sep 4;23(17):10122. doi: 10.3390/ijms231710122.
7
Comparison of the Behavior of Perivascular Cells (Pericytes and CD34+ Stromal Cell/Telocytes) in Sprouting and Intussusceptive Angiogenesis.血管周细胞(周细胞和 CD34+基质细胞/间质细胞)在发芽和出芽性血管生成中的行为比较。
Int J Mol Sci. 2022 Aug 12;23(16):9010. doi: 10.3390/ijms23169010.
8
Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation.基质金属蛋白酶10促成脉络膜新生血管形成。
Biomedicines. 2022 Jun 30;10(7):1557. doi: 10.3390/biomedicines10071557.
9
Endoglin Modulates TGFβR2 Induced VEGF and Proinflammatory Cytokine Axis Mediated Angiogenesis in Prolonged DEHP-Exposed Breast Cancer Cells.内皮糖蛋白调节转化生长因子β受体2诱导的血管内皮生长因子和促炎细胞因子轴介导的血管生成,该血管生成发生在长期暴露于邻苯二甲酸二(2-乙基己基)酯的乳腺癌细胞中。
Biomedicines. 2022 Feb 10;10(2):417. doi: 10.3390/biomedicines10020417.
10
Selected Biomarkers of Tick-Borne Encephalitis: A Review.蜱传脑炎的候选生物标志物:综述。
Int J Mol Sci. 2021 Sep 30;22(19):10615. doi: 10.3390/ijms221910615.

本文引用的文献

1
Membrane-type 1 matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation.膜型1基质金属蛋白酶通过表皮生长因子受体反式激活刺激细胞迁移。
Mol Cancer Res. 2007 Jun;5(6):569-83. doi: 10.1158/1541-7786.MCR-06-0267. Epub 2007 May 31.
2
The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells.成纤维细胞的血管内皮生长因子(VEGF)血管生成开关受癌细胞来源的基质金属蛋白酶-7(MMP-7)调控。
Oncogene. 2007 Nov 8;26(51):7194-203. doi: 10.1038/sj.onc.1210535. Epub 2007 May 21.
3
Molecular regulation of angiogenesis and lymphangiogenesis.血管生成与淋巴管生成的分子调控。
Nat Rev Mol Cell Biol. 2007 Jun;8(6):464-78. doi: 10.1038/nrm2183.
4
Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation.间充质干细胞通过早期上调基质金属蛋白酶增强机械存活的预血管化组织中的血管生成。
Tissue Eng. 2006 Oct;12(10):2875-88. doi: 10.1089/ten.2006.12.2875.
5
VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases.血管内皮生长因子增加纤维蛋白基质内内皮细胞的纤溶活性:血管内皮生长因子受体-2、组织型纤溶酶原激活物和基质金属蛋白酶的参与
Thromb Res. 2007;121(2):203-12. doi: 10.1016/j.thromres.2007.03.024. Epub 2007 May 21.
6
Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.3,3'-二吲哚甲烷对血管生成和侵袭的抑制作用是由核因子-κB下游靶基因MMP-9和uPA介导的,这些基因调节前列腺癌中血管内皮生长因子的生物利用度。
Cancer Res. 2007 Apr 1;67(7):3310-9. doi: 10.1158/0008-5472.CAN-06-4277.
7
Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells.新生血管与壁细胞之间的串扰将MT1-MMP的位点特异性表达导向内皮尖端细胞。
J Cell Sci. 2007 May 1;120(Pt 9):1607-14. doi: 10.1242/jcs.000679. Epub 2007 Apr 3.
8
Regulation of MMP-2 gene transcription in dermal wounds.真皮伤口中基质金属蛋白酶-2(MMP-2)基因转录的调控
J Invest Dermatol. 2007 Jul;127(7):1762-7. doi: 10.1038/sj.jid.5700765. Epub 2007 Mar 8.
9
Matrix metalloproteinases and the regulation of tissue remodelling.基质金属蛋白酶与组织重塑的调控
Nat Rev Mol Cell Biol. 2007 Mar;8(3):221-33. doi: 10.1038/nrm2125.
10
Regulation of matrix metalloproteinase gene expression.基质金属蛋白酶基因表达的调控
J Cell Physiol. 2007 Apr;211(1):19-26. doi: 10.1002/jcp.20948.